Advertisement

Topics

Companies Related to "The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache" [Most Relevant Company Matches] RSS

03:44 EST 21st February 2019 | BioPortfolio

Here are the most relevant search results for "The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache" found in our extensive corporate database of over 50,000 company records.

Showing "Effect Sumatriptan Placebo Isosorbide mononitrate Induced Headache" Companies 1–25 of 259

Extremely Relevant

International Headache Society

The International Headache Society is the world’s leading membership organization for all whose professional commitment, whatever their discipline, is to helping people whose lives are affected by headache. As a charity, the purpose of IHS is to advance headache science, education, and management, and promote headache awareness worldwide. Activities i...


Relevant

Houston Headache Clinic

The Houston Headache Clinic, widely recognized as one of the premiere headache centers in the country, was established in 1976 for the diagnosis and management of headache problems. The physicians and staff of the Houston Headache Clinic treat each patient as a partner in the treatment of his or her own headache disorder, and patient education is central to this practice. Physicians, physician ass...

Diamond Headache Clinic

For thousands of Americans, headache and migraine pain is a serious drain on productivity and quality of life. According to a recent national survey by Louis Harris & Associates, nearly 75 percent of all Americans age 18 and over suffer one or more headaches per year; more than 40 percent have six or more in the same period. The economic consequences are staggering. The Harris survey estimated tha...


Zogenix, Inc.

Zogenix, Inc., with offices in Emeryville and San Diego, Calif., is a privately held pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. The company is commercially focused on SUMAVEL(TM) DosePro(TM) (sumatriptan injection) needle-free delivery system, which launched in January 2010, for the acute treatment of migraine and ...

Fullerton Neurology and Headache Center

Fullerton Neurology and Headache Center is a state-of-the art medical office strategically located near St. Jude Medical Center. The Center is fitted with larger exam rooms, an Infusion Suite and is designed to be easily accessible.

Privia

A clinical trial is a research study. Research studies are used to decide how treatments work and how safe they are. While in a study, a person may receive either an investigational drug, a marketed drug, a placebo, or a combination of these. An investigational drug is one that is nor approved by the Food and Drug Administration, a marketed drug is FDA approved and a placebo is like a "sugar pill"...

Eminent effect

The eminent effect is a consultancy aiming to stand out from the crowd in tackling many of today’s people and business challenges. The company offers organisation specific training, development, sales/marketing and interim management solutions not off the shelf packages.Primarily working within the NHS, Pharmaceutical and Biotechnology sectors, the eminent effect personnel can offer experience g...

Winston Pharmaceuticals, Inc.

Winston is a pharmaceutical company focused on pain control which is developing products for large pain control markets, as well as for niche markets, where there are still significant unmet needs for pain management options with improved efficacy, safety, and tolerability profiles. Winston's late stage product candidates include osteo- and rheumatoid arth...

Headache, MD

Curelator Headache

National Headache Foundation

American Headache Society

CorMedix Inc.

CorMedix Inc. is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction, also known as cardiorenal disease. CorMedix’s goal is to treat kidney disease by reducing the commonly associated cardiovascular and metabolic complications, in effect, tr...

Adeona Pharmaceuticals, Inc.

Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Adeona's primary strategy is to in-license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to an inflection point in valuation resulting in a significant development and marketing collaboration. Trimesta (estriol) ...

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Tricida, Inc.

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of TRC101, a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. Tricida has successfully...

DiaTech Oncology

DiaTech Oncology is a privately held clinical pathology laboratory that offers patient-specific chemotherapy testing to help oncologists determine the best cancer treatment plans for their patients. DiaTech utilizes a patented technology called the Microculture Kinetic (MiCK) assay, which measures apoptosis (cell death) induced in a specific patient’s...

GWC Technologies

GWC Technologies is the emerging leader in “label-free” detection systems for life science research. The company develops, manufactures and markets label-free detection systems for:Detection of biomolecular interactions, and Measurements of surface film thickness. GWC's technology platform is centered on Surface Plasmon Resonance (SPR), an electro-optical effect that facilitates measurements o...

Ipsen Biopharmaceuticals, Inc.

*MAS responders week 4: 74% to Dysport® 500 units, 79% to Dysport® 1000 units and 23% to placebo

Orasi Medical

Orasi Medical develops products to measure the effect of neurological treatments and track the progression of neurological disorders. Pharmaceutical companies use Orasi Index(TM), the company's flagship product, to reduce costs and improve clinical development of neurological treatments. Orasi's high-resolution measurement of brain function provides a robust, non-invasive and reproducible measure ...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combinati...

DiObex, Inc.

DiObex is a biotechnology company engaged in the development of novel products for metabolic disease. DIO-901 (very low dose glucagon) is in development in two convenient delivery forms for the prevention of nocturnal hypoglycemia induced by insulin intensification. Insulin-induced hypoglycemia, which occurs most frequently at night, is a major limitation in the aggressive management of hype...

Numab

Founded in 2011, Numab discovers and develops innovative antibody-based therapeutics. Applying proprietary rabbit-based antibody discovery and engineering technology, Numab generates highly potent and stable antibody Fv fragments, which serve as building blocks to create mono- or bi-specific antibody fragment-based therapeutics with tailored pharmacokineti...

Probably Relevant

MonoSol Rx, LLC

MonoSol Rx is a specialty pharmaceutical company leveraging its proprietary PharmFilm® technology to deliver drugs in films. PharmFilm® is designed to benefit patients by improving the convenience, efficacy, and compliance of new and currently marketed drugs. The Company's leadership in film drug delivery is supported by strong intellectual property, a portfolio of commercialized prescription an...

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. In the process, Tosk discovered and perfected the Optimizing Marketed Drugs side-effect-reducing drugs.Tosk's current drug discovery and development efforts focus on applying the OMD approach to disco...


More From BioPortfolio on "The Effect of Sumatriptan and Placebo on Isosorbide-5-mononitrate Induced Headache"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks